276 related articles for article (PubMed ID: 35116092)
1. Cancer cells with irons in the fire.
Bystrom LM; Rivella S
Free Radic Biol Med; 2015 Feb; 79():337-42. PubMed ID: 24835768
[TBL] [Abstract][Full Text] [Related]
2. Iron metabolism in the eye: a review.
Goralska M; Ferrell J; Harned J; Lall M; Nagar S; Fleisher LN; McGahan MC
Exp Eye Res; 2009 Feb; 88(2):204-15. PubMed ID: 19059397
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Iron-Chelating Agent Can Maintain Bone Homeostasis Disrupted by Iron Overload by Upregulating Wnt/Beta-Catenin Signaling.
International BR
Biomed Res Int; 2024; 2024():9816567. PubMed ID: 38550044
[TBL] [Abstract][Full Text] [Related]
4. Role of Iron Accumulation in Osteoporosis and the Underlying Mechanisms.
Li GF; Gao Y; Weinberg ED; Huang X; Xu YJ
Curr Med Sci; 2023 Aug; 43(4):647-654. PubMed ID: 37326889
[TBL] [Abstract][Full Text] [Related]
5. The Role of Trace Elements in Cardiovascular Diseases.
Wechselberger C; Messner B; Bernhard D
Toxics; 2023 Nov; 11(12):. PubMed ID: 38133357
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of iron on the intestinal epithelium development in suckling piglets.
Yin L; Zhang Y; Li J; Zhou J; Wang Q; Huang J; Li J; Yang H
Sci China Life Sci; 2023 Sep; 66(9):2070-2085. PubMed ID: 37233872
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of desferrioxamine mesylate in intracerebral hematoma: a systemic review and meta-analysis.
Zhao K; Li J; Zhang Q; Yang M
Neurol Sci; 2022 Dec; 43(12):6771-6782. PubMed ID: 36006553
[TBL] [Abstract][Full Text] [Related]
8. Emerging Roles of the Iron Chelators in Inflammation.
Di Paola A; Tortora C; Argenziano M; Marrapodi MM; Rossi F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887336
[TBL] [Abstract][Full Text] [Related]
9. mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases.
Wang Y; Fung NSK; Lam WC; Lo ACY
Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883796
[TBL] [Abstract][Full Text] [Related]
10. Iron-Chelating Agent Can Maintain Bone Homeostasis Disrupted by Iron Overload by Upregulating Wnt/Beta-Catenin Signaling.
Xu W; Yu R; Zhu X; Li Z; Jia J; Li D; Chen Y; Zhang X
Biomed Res Int; 2020; 2020():8256261. PubMed ID: 32596380
[TBL] [Abstract][Full Text] [Related]
11. Synthetic and natural iron chelators: therapeutic potential and clinical use.
Hatcher HC; Singh RN; Torti FM; Torti SV
Future Med Chem; 2009 Dec; 1(9):1643-70. PubMed ID: 21425984
[TBL] [Abstract][Full Text] [Related]
12. Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology.
Kontoghiorghe CN; Kolnagou A; Kontoghiorghes GJ
Molecules; 2015 Nov; 20(11):20841-72. PubMed ID: 26610453
[TBL] [Abstract][Full Text] [Related]
13. Canonical Wnt Signaling in the Pathology of Iron Overload-Induced Oxidative Stress and Age-Related Diseases.
Armstrong A; Mandala A; Malhotra M; Gnana-Prakasam JP
Oxid Med Cell Longev; 2022; 2022():7163326. PubMed ID: 35116092
[TBL] [Abstract][Full Text] [Related]
14. A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload.
Sripetchwandee J; Wongjaikam S; Krintratun W; Chattipakorn N; Chattipakorn SC
Neuroscience; 2016 Sep; 332():191-202. PubMed ID: 27403880
[TBL] [Abstract][Full Text] [Related]
15. Canonical Wnt signaling works downstream of iron overload to prevent ferroptosis from damaging osteoblast differentiation.
Luo C; Xu W; Tang X; Liu X; Cheng Y; Wu Y; Xie Z; Wu X; He X; Wang Q; Xiao Y; Qiu X; Tang Z; Shao G; Tu X
Free Radic Biol Med; 2022 Aug; 188():337-350. PubMed ID: 35752374
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
